About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNCT02453035

DESolve® X-Pand Global Post Market Registry

The X-Pand Registry is intended to facilitate analysis of acute \& long-term safety as well as treatment outcomes with DESolve in patients with CAD.

Lead sponsor: Elixir Medical Corporation•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Elixir Medical Corporation

Collaborators

European Cardiovascular Research Center

The Xpand Registry is a single-arm, multi-center, clinical Follow up study of patients with significant coronary stenosis who are treated with a commercially available DESolve Scaffold. The Registry is an observational study. The patients should be treated according to the current DESolve IFU, professional societies guidelines \& internal hospital guidelines.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Minimal age 18 years
•2. Patient is willing/able to cooperate with study procedures and required follow up visits. Patient or legal representative has been informed \& agrees by signing EC approved written consent. Consent can occur before implantation of the DESolve scaffold (planned procedure) or within 30 days post implantation procedure for retrospective enrollment (unplanned procedure).
•3. Planned or unplanned DESolve scaffold implantation

Exclusion Criteria

•None

Related studies

Deep Learning CAD Screening on Chest CT

NCT07181512 · Coronary Artery Disease, Coronary Artery Stenosis Stent

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

NCT05831085 · Coronary Artery Stenosis

Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study

NCT05860400 · Coronary Artery Disease, Coronary Artery Stenosis, and more

Disease Characteristics of IR-CAD: a Case-control Study

NCT06007248 · Coronary Artery Disease, Coronary Artery Stenosis, and more

Complete Functional Assessment of Intermediate Coronary Artery Stenosis Before and After Transcatheter Aortic Valve Implantation (TAVI) in Patients With Severe Symptomatic Aortic Valve Stenosis

NCT05133843 · Coronary Artery Stenosis, Transcatheter Aortic Valve Implantation

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 26, 2021Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment154

Start dateMay 2015

Last updatedApr 26, 2021

Condition

Coronary Artery Stenosis

Locations shown

Kerckhoff-Klinik

Bad Nauheim

Universitätsklinikum Giessen

Giessen

GPR Klinikum Rüsselsheim

Rüsselsheim am Main

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 26, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions